Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs Tablet Health

AgelessRx
Graded #24

Higher grade

vs+36.699999999999996
Tablet Health
Graded #495

Lower grade

The verdict

AgelessRx takes it — 84.3/100 to 47.6/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Among the lowest compounded-semaglutide pricing, with some brand-name access.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgelessRx +45
90
45
Dose & formulationAgelessRx +29
80
51
Clinical oversightAgelessRx +46
83
37
Labs & monitoringAgelessRx +32
82
50
FulfillmentAgelessRx +27
84
57
Contract termsAgelessRx +30
85
55
AgelessRx · left barTablet Health · right bar

The numbers

MetricAgelessRxTablet Health
WeighScore84.3/10047.6/100
GradeBC
Scorecard rank#24#495
Semaglutide$139/moNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageNot disclosedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
AgelessRx

Graded #24 · B

Strengths

  • Low-end semaglutide pricing
  • Some brand-name access
  • Established brand

Where it loses points

  • Tirzepatide pricing not disclosed
  • States not disclosed
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard